PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18609142-0	2008	Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a.	telaprevir	119-129	glutamic--pyruvic transaminase	Homo sapiens	35-59	
18609142-0	2008	Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a.	telaprevir	131-137	glutamic--pyruvic transaminase	Homo sapiens	35-59	
18609142-6	2008	Mean neopterin and ALAT levels decreased in all four groups receiving telaprevir alone.	telaprevir	70-80	glutamic--pyruvic transaminase	Homo sapiens	19-23	
18609142-9	2008	The increase in neopterin levels and the decrease in ALAT levels during administration of Peg-IFN with or without telaprevir are in accordance with earlier observations showing that IFN reduces hepatocyte injury but increases monocyte/macrophage activity.	telaprevir	114-124	glutamic--pyruvic transaminase	Homo sapiens	53-57